Not applicableStudy completedNCT01823172What this trial is testingSecond Echelon Node Study With Methylene BlueWho this might be right forBreast CancerMelanoma Mayo Clinic 21
Very early researchUnknownNCT05180851What this trial is testingSafety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyWho this might be right forHead and Neck CancerMelanomaBreast Cancer+4 more Shanghai Fengxian District Central Hospital 28
Large-scale testing (Phase 3)Study completedNCT02997553What this trial is testingFluorescence for Sentinel Lymph Node Identification in Cancer SurgeryWho this might be right forBreast CarcinomaHead and Neck CancerMelanoma (Skin)+7 more Institut de Cancérologie de Lorraine 744
Not applicableStudy completedNCT00880503What this trial is testingCollection of Tissue Samples for Study of Multidrug ResistanceWho this might be right forBreast CarcinomaBreast CancerMedullary Thyroid Carcinoma National Cancer Institute (NCI) 325
Early research (Phase 1)Study completedNCT01351103What this trial is testingLGK974 in Patients With Malignancies Dependent on Wnt LigandsWho this might be right forPancreatic CancerBRAF Mutant Colorectal CancerMelanoma+5 more Novartis Pharmaceuticals 185
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128What this trial is testingSelpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Who this might be right forNon-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more Eli Lilly and Company 857
Early research (Phase 1)Study completedNCT01391143What this trial is testingSafety Study of MGA271 in Refractory CancerWho this might be right forProstate CancerMelanomaRenal Cell Carcinoma+4 more MacroGenics 179
Not applicableLooking for participantsNCT05037825What this trial is testingThe Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid TumorsWho this might be right forNon-Small-Cell Lung CarcinomaMalignant MelanomaRenal Cell Carcinoma+1 more VastBiome 800
Testing effectiveness (Phase 2)Ended earlyNCT03277352What this trial is testingINCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)Study completedNCT03126110What this trial is testingPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)Study completedNCT02460224What this trial is testingSafety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.Who this might be right forAdvanced Solid Tumors Novartis Pharmaceuticals 490
Not applicableLooking for participantsNCT07469709What this trial is testingBiological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer RisksWho this might be right forBreast CancerColo-rectal CancerOvarian Cancer+2 more Fondazione del Piemonte per l'Oncologia 850
Not applicableLooking for participantsNCT07327489What this trial is testingPredicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)Who this might be right forCancerImmunotherapyAdvanced Solid Tumors Cancer+12 more Elephas 2,000
Not applicableActive Not RecruitingNCT03285230What this trial is testingThe French E3N Prospective Cohort StudyWho this might be right forBreast CancerColo-rectal CancerParkinson Disease+11 more Institut National de la Santé Et de la Recherche Médicale, France 100,000
Testing effectiveness (Phase 2)WithdrawnNCT03326258What this trial is testingGlembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07524114What this trial is testingStudy of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)Who this might be right forBreast CancerLung CancerMelanoma+7 more University Health Network, Toronto 7,000
Early research (Phase 1)Study completedNCT02639026What this trial is testingTrial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic CancersWho this might be right forMetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more Abramson Cancer Center at Penn Medicine 53
Not applicableStudy completedNCT00132704What this trial is testingAn Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationWho this might be right forOvarian NeoplasmsColorectal NeoplasmsMelanoma+2 more Memorial Sloan Kettering Cancer Center 149
Not applicableStudy completedNCT04604158What this trial is testingEvaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsWho this might be right forCancerCancer MetastaticNeoplasms+20 more Gillian Gresham 38